Jeroen Van Houdt
Omics Group Leader
Janssen R&D BE
Why I'm a JPAL
Novel technologies for biological research are integral to scientific progress. Technological advances enable researchers to study biological process in more detail and address novel experimental questions that were not possible before. I enjoy working on this interface between technology and biology. It is fascinating to see how technological innovation is changing the way we look at biological processes.
As Omics Group Leader I try to assure that our research teams have access to state-of-the-art single cell omics technologies. I’m excited to use my expertise/interest in disease biology, novel omics technologies and data analytics to identify and implement innovative approaches to address novel biological questions and ultimately develop better therapeutics. Before joining J&J in 2017 I was heading the genomics facility in Leuven, a joined venture between the university (KUL) and university hospital (UZ). The mission of this platform is to advance and develop novel genomics technologies to support basic research and to translate these novel technologies into next generation diagnostics to support clinical decision making. I was trained as a molecular geneticist and developed bioinformatics and data analytics skills during my PhD and Postdoc.
“It does not matter how slowly you go, so long as you do not stop.”
I like to play soccer/football